Dan Su

Title: Dan Su - Innovator in Synthetic Antibody Mimic Peptides

Introduction

Dan Su is a prominent inventor based in Fremont, CA. He has made significant contributions to the field of biotechnology, particularly in the development of synthetic antibody mimic peptides. His work focuses on creating peptide molecules that replicate the binding and functional properties of native antibodies.

Latest Patents

Dan Su holds a patent for synthetic antibody mimic peptides. This patent encompasses compositions and methods that include peptide molecules designed to mimic the binding and functional properties of native antibodies relative to their respective targets. The targets of these mimic peptides include epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), vascular endothelial growth factor (VEGF), programmed cell death protein 1 (PD-1), and programmed death-ligand 1 (PD-L1). The patent also discusses the application of the knob-socket computational model to design antibody mimics for proteins.

Career Highlights

Dan Su is currently associated with Formurex, Inc., where he continues to advance his research in synthetic peptides. His innovative approach has the potential to impact therapeutic strategies in various medical fields.

Collaborations

Dan has collaborated with notable colleagues, including Xiaoling Li and Jerry Tsai, who contribute to the research and development efforts at Formurex, Inc.

Conclusion

Dan Su's work in synthetic antibody mimic peptides represents a significant advancement in biotechnology. His innovative contributions are paving the way for new therapeutic approaches in medicine.